Safer Antidepressants with Bleeding Risk?
BEFORE SCROLLING DOWN ==>
SUBMIT YOUR ANSWERS FIRST 🙂
.
.
.
.
What is the Underlying Mechanism?
SSRIs limit uptake of blood serotonin by platelets. Since platelets are unable to synthesize serotonin, this leads to a lower concentration of serotonin within the platelets, and because one of the functions of serotonin within the platelets is to promote platelet aggregation, a decreased amount of serotonin in the platelets may increase the risk of abnormal bleeding.
Q: Which Antidepressants are considered safe in patients at risk of abnormal bleeding?
Antidepressant drugs which do not inhibit the reuptake of serotonin are likely to be safe in patients at risk of abnormal bleeding. These drugs include:
- Mirtazapine
- Bupropion
- Moclobemide
- Reboxetine
References:
- Arch Intern Med. 2004;164(21):2367-2370;
- BMJ 2001;323:655
- Arch Intern Med. 2004;164(21):2367-2370
Q: What if the patient is either unable to tolerate or has contraindications for the above medications?
Q: How can you reduce the risk of upper gastrointestinal bleeding with SSRIs?
Psychiatry Education Forum Academy will answer these questions in following chapter:
Antidepressants & risk of BLEEDING: Thrombocytopenia Evaluation
INTERESTED IN LEARNING MORE?
JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP
This is a closed membership for medical professionals only.
- 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice.
- Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
- Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
- Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections.
- Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
- Conference Discounts: Academy members get discounted access at our conferences.
- Goal: is to have all important clinically relevant topics in one place for ease of access.
